Overexpression of LAPTM4B: an independent prognostic marker in breast cancer

LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors

(2011) Mingzhu Yin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer

(2011) Mingzhu Yin et al.   JOURNAL OF SURGICAL ONCOLOGY

Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells

(2011) Li Zhou et al.   SURGERY

LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma

(2010) Fan-ling Meng et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Overexpression of LAPTM4B-35 in Cervical Carcinoma

(2010) Fanling Meng et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

(2010) Yang Li et al.   NATURE MEDICINE

LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling

(2010) L Li et al.   ONCOGENE

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma

(2009) Hua Yang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Early breast cancer

(2009) John R Benson et al.   LANCET

Expression of LAPTM4B-35: A novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma

(2008) Li Zhou et al.   CANCER LETTERS